Clinical Trial Update: Imetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial of imetelstat sodium in adults with primary or secondary myelofibrosis has completed enrollment and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Myeloid Malignancies

Drugs mentioned

• imetelstat sodium (imetelstat)

Snippet

Sponsor: Geron Corporation | Conditions: Primary Myelofibrosis, Secondary Myelofibrosis | Phase 2 | Status: COMPLETED | Results posted: 2021-09-21